IdentifyPast Due

Next-Gen Internal Audit Consolidation - FY25

ID: 4300377-30

Potential Value

$101,839

Deal Value

$0

Stated Probability

100%

Days in Pipeline

695

Client & Account

Client

Phoenix Pharmaceutical Foundation

City

Philadelphia

Region

USLI

Sub-Sector

SLED

Service Classification

Service Line

SaT

Field of Play

Transactions

Opportunity Sub-SL

Transactions & Corporate Finance

Competency

TCF - Sell & Separate

Global Service Code

Process Reengineering (41277)

People & Dates

Partner

Tanaka Pamela

Pursuit Leader

Mendoza Betty

Open Date

Jun 17, 2024

Anticipated Win Date

Apr 1, 2026

Close Date

N/A

Details

Description

Next-Gen Internal Audit Consolidation - FY25

No win probability predictions available for this opportunity.